Mirum Pharmaceuticals (MIRM) PT Lowered to $137 at Citizens
Tweet
Share
E-mailGet Alerts MIRM Hot Sheet
Price: $100.63 --0%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Join SI Premium – FREE
Citizens analyst Jonathan Wolleben lowered the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $137.00 (from $146.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Freedom Broker Downgrades Ero Copper (ERO) to Hold
- Docusign Inc. (DOCU) PT Raised to $75 at Morgan Stanley
- Lonza Group (LONN:SW) (LZAGY) PT Raised to CHF630 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
